Condition: First Trimester Abortion · Surgical Abortion · Miscarriage With Afibrinogenemia · Sponsor: Chinese University of Hong Kong
The objective of this prospective, randomized controlled study was to evaluate the effectiveness of this NCH gel in the prevention of IUA development as assessed by hysteroscopy after USG-MVA, in the treatment for first-trimester miscarriage. * To study the severity and extent of the IUA as assessed by the AFS and ESGE adhesion score in both groups of patients. * To examine the rate of complications or side effects with the NCH gel. * To assess the subsequent menstrual history and reproductive outcome in both groups of patients.
This description comes directly from the study's public registry record.
Elaine NG · 35052745 · elaineng@cuhk.edu.hk
Stacey Wong, Bsc · 35051764 · staceywong@cuhk.edu.hk
Always discuss trial participation with your own doctor first.
| The Chinese University of Hong Kong | Hong Kong, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05360186